Clinilabs is excited to attend the Psychedelic Science Conference, hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS), this June in Denver, Colorado. Psychedelic medicine has shown significant improvements in reducing depressive and anxious symptoms, along with enhancing emotional well-being. Notably, these improvements tend to increase in magnitude with greater exposure to psychedelics. Clinilabs is at the forefront of clinical research and aims to be a key partner in bringing these medications to market.

We are eager to connect with fellow researchers to further explore and educate others about the medical, legal, and cultural contexts surrounding the careful use of psychedelics as a treatment option. We are excited to be part of a community where advanced psychedelic-assisted therapies can assist those most affected by trauma.

To book a meeting with us while we are here visit Schedule Meeting now and find out how we can help bring your treatment to market.